Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

ChemoCentryx Inc. (CCXI)

54.8   1.27 (2.37%) 10-01 08:44
Open: 53.32 Pre. Close: 53.53
High: 55.475 Low: 53.15
Volume: 715,620 Market Cap: 3,775M
ChemoCentryx, Inc. is a biopharmaceutical company engages in the development and commercialization of medicines. The company is headquartered in Mountain View, California and currently employs 76 full-time employees. The firm is engaged in developing new medications targeted at inflammatory disorders, autoimmune diseases and cancer. Each of its drug candidates focuses on a specific chemoattractant receptor that selectively blocks its negative inflammatory or suppressive response, leaving the rest of the immune system intact. Its late stage compounds include Avacopan (CCX168) and CCX140. Avacopan (CCX168) is an orally administered complement inhibitor targeting the C5a receptor (C5aR), and is being developed for orphan and rare diseases, including anti-neutrophil cytoplasmic auto-antibody associated vasculitis (AAV); atypical hemolytic uremic syndrome (aHUS), and complement 3 glomerulopathy (C3G). CCX140 is an orally administered inhibitor of the chemokine receptor known as C-C chemokine receptor type 2 (CCR2), in development for diabetic nephropathy (DN), a form of chronic kidney disease (CKD), and for focal segmental glomerulosclerosis (FSGS).

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 54.335 - 54.525 54.525 - 54.698
Low: 52.464 - 52.708 52.708 - 52.932
Close: 53.303 - 53.643 53.643 - 53.955

Technical analysis

as of: 2020-09-30 4:39:42 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 66.00     One year: 77.09
Support: Support1: 49.58    Support2: 45.29
Resistance: Resistance1: 56.51    Resistance2: 66.00
Pivot: 51.93
Moving Average: MA(5): 52.52     MA(20): 51.23
MA(100): 55.64     MA(250): 42.25
MACD: MACD(12,26): 0.15     Signal(9): -0.22
Stochastic oscillator: %K(14,3): 70.42     %D(3): 64.49
RSI: RSI(14): 54.23
52-week: High: 65.43  Low: 6.77  Change(%): 679.2
Average Vol(K): 3-Month: 57532  10-Days: 81356

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
CCXI has closed below upper band by 29.7%. Bollinger Bands are 7.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 30 Sep 2020
-$0.28 Earnings Per Share Expected for ChemoCentryx Inc (NASDAQ:CCXI) This Quarter - MarketBeat

Mon, 21 Sep 2020
ChemoCentryx Inc. (CCXI) last month performance of 2.07% certainly makes it a sizzling prospect - News Daemon

Sun, 20 Sep 2020
Rock star Growth Puts ChemoCentryx (NASDAQ:CCXI) In A Position To Use Debt - Simply Wall St

Fri, 18 Sep 2020
ChemoCentryx Inc. (CCXI) Soars 5.21% on September 18 - Equities.com

Thu, 17 Sep 2020
ChemoCentryx (CCXI) Reports FDA Acceptance of the Avacopan NDA for Treatment of ANCA-Associated Vasculitis - StreetInsider.com

Wed, 16 Sep 2020
Do Analysts Expect ChemoCentryx Inc (CCXI) Stock to Rise? - InvestorsObserver

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 69
Shares Float (M) 48
% Held by Insiders 28.93
% Held by Institutions 67.08
Shares Short (K) 5,270
Shares Short P. Month (K) 5,090

Stock Financials

EPS -0.500
EPS Est This Year -0.900
EPS Est Next Year -1.360
Book Value (p.s.) 6.120
Profit Margin -39.18
Operating Margin -41.39
Return on Assets (ttm) -5.1
Return on Equity (ttm) -12.1
Qtrly Rev. Growth 589.3
Gross Profit (p.s.) -0.496
Sales Per Share 1.104
EBITDA (p.s.) -0.449
Qtrly Earnings Growth
Operating Cash Flow (M) -83
Levered Free Cash Flow (M) -6

Stock Valuations

PE Ratio -107.38
PEG Ratio
Price to Book value 8.77
Price to Sales 48.62
Price to Cash Flow -44.71

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.